F
N+ Score59
Weight ManagementServing: 1 Veggie Capsule(s)Type: Other Combinations

Metapan from Marco Pharma Int'l is a weight management supplement featuring a proprietary blend at 1198mg, alongside Alpha Lipoic Acid at 20mg and L-Carnitine Tartrate at 50mg. These ingredients are often researched for their potential roles in metabolism and energy. The product holds an N+ Score of 59, resulting in an 'F' grade, indicating an average quality assessment. With 3 ingredients and 100% label transparency, a significant portion of the formula is undisclosed within the proprietary blend, making it challenging to evaluate individual ingredient efficacy. Furthermore, the Alpha Lipoic Acid and L-Carnitine Tartrate dosages are considerably below levels typically studied in clinical research for their purported benefits. This product may be considered by those exploring general metabolic support, but its underdosed active ingredients and proprietary blend limit its potential effectiveness.

About This Product

Metapan by Marco Pharma Int'l is a weight management supplement containing 3 active ingredients. It has earned an N+ Score of 59/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Alpha Lipoic Acid20.000 mgN/A
L-Carnitine Tartrate50.000 mgN/A
Proprietary Blend (Combination)1198.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.